The CD99 IHC test detects the presence of CD99, a transmembrane glycoprotein expressed on the surface of certain cells. This marker is commonly used in the evaluation of small round blue cell tumors, such as Ewing sarcoma/primitive neuroectodermal tumor (PNET), lymphoblastic lymphoma, and other neoplasms.